Citation: | LYUXing, LYUGao-hong, YEGuan. Protective Effect of Xiangshenke Formula on the Epithelial Mesenchymal Transformation and Metastasis of Human Gastric Carcinoma Cells[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(6): 687-690. |
[1] |
VAN CUTSEM E, SAGAERT X, TOPAL B, et al. Gastric cancer[J]. Lancet, 2016, 388(10060): 2654-2664.
|
[2] |
FIDLER IJ. The pathogenesis of cancer metastasis: The "seed and soil" hypothesis revisited[J]. Nat Rev Cancer, 2003, 3(6): 453-458.
|
[3] |
YONEMURA Y , BANDOU E , KAWAMURA T , et al. Quantitative prognostic indicators of peritoneal dissemination of gastric cancer[J]. Europ J Surgic Oncol, 2006, 32(6):602-606.
|
[4] |
LIU J, WANG S, ZHANG Y, et al. Traditional Chinese medicine and cancer: History, present situation, and development[J]. Thoracic Cancer, 2015, 6(5): 561-569.
|
[5] |
徐淑云, 卞如濂, 陈修. 药理实验方法学[M].3版. 北京: 人民卫生出版社, 2005: 203.
|
[6] |
潘卫松, 刘美凤, 石钺, 等. 血清药理学、血清化学和中药药代动力学[J]. 世界科学技术—中医药现代化, 2002, 4(3):53-56.
|
[7] |
李仪奎. 中药血清药理学实验方法的若干问题[J]. 中药新药与临床药理, 1999,10(2):95-98.
|
[8] |
鄂征. 组织培养和分子细胞学技术[M]. 北京:北京出版社, 2001:207-214.
|
[9] |
王力倩, 李仪奎, 符胜光, 等. 血清药理学方法研究探索[J]. 中药药理与临床, 1997,10(3):29-31.
|
[10] |
ZHANG F, ZHANG X, LI M, et al. mTOR complex component Rictor interacts with PKC zeta and regulates cancer cell metastasis[J]. Cancer Res, 2010, 70(22):9360-9370.
|
[11] |
王晓君, 吴乾. 中医健脾祛瘀法治疗胃癌的应用与疗效评价[J]. 中国药物与临床, 2018,18(1): 117-118.
|
[12] |
FELIPE LJ, NOFECH-MOZES S, BAYANI J, et al. EMT in breast carcinoma:A review[J]. J Clin Med, 2016, 5(7): 65-79.
|
[13] |
MOHAMMED MK, SHAO C, WANG J, et al. Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance[J]. Gene Dis, 2016, 3(1):11-40.
|
[14] |
FASSAN M, SIMBOLO M, BRIA E, et al. High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers[J]. Gastric Cancer, 2014, 17(3): 442-449.
|
[15] |
ANASTAS JN, MOON RT. WNT signalling pathways as therapeutic targets in cancer[J]. Nat Rev Cancer, 2013, 13(1): 11-26.
|
[16] |
WU J, ZHANG HT, XU C, et al. TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastriccancer[J]. Int J Oncol, 2016, 48(1):199-206.
|